{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:21:17Z","timestamp":1771597277956,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12685-0","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:45:57Z","timestamp":1769615157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low necessity, high overuse: revisiting empirical vancomycin practices for children in low MRSA prevalence settings"],"prefix":"10.1186","volume":"26","author":[{"given":"Phuwakrit","family":"Nithirungruang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonnamet","family":"Techasaensiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophida","family":"Boonsathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujittra","family":"Chaisavaneeyakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nopporn","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"12685_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0196-6553(95)90104-3","volume":"23","author":"Recommendations for preventing the spread of vancomycin","year":"1995","unstructured":"Recommendations for preventing the spread of vancomycin. Resistance: recommendations of the hospital infection control practices advisory committee (HICPAC). Am J Infect Control. 1995;23:87\u201394.","journal-title":"Am J Infect Control"},{"key":"12685_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49:1\u201345.","journal-title":"Clin Infect Dis"},{"key":"12685_CR3","unstructured":"Pediatric Infectious Disease Society of Thailand. Clinical practice guideline of acute meningoencephalitis [Internet]. 2014. Available at: https:\/\/www.pidst.or.th\/A488.html. Accessed October 10, 2023."},{"issue":"Suppl 1","key":"12685_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2165\/00003495-199600511-00004","volume":"51","author":"MG Cormican","year":"1996","unstructured":"Cormican MG, Jones RN. Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, Staphylococci and Nonpneumococcal Streptococci. Drugs. 1996;51(Suppl 1):6\u201312.","journal-title":"Drugs"},{"key":"12685_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jgar.2025.01.016","volume":"41","author":"AC Almeida-Santos","year":"2025","unstructured":"Almeida-Santos AC, Novais C, Peixe L, Freitas AR. Vancomycin-resistant Enterococcus faecium: A current perspective on resilience, adaptation, and the urgent need for novel strategies. J Glob Antimicrob Resist. 2025;41:233\u201352.","journal-title":"J Glob Antimicrob Resist"},{"key":"12685_CR6","doi-asserted-by":"crossref","unstructured":"Radford-Smith DE, Anthony DC, Vancomycin-Resistant E. Faecium: addressing global and clinical challenges. Antibiot (Basel). 2025;14(5).","DOI":"10.3390\/antibiotics14050522"},{"key":"12685_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2334-7-88","volume":"7","author":"MS Junior","year":"2007","unstructured":"Junior MS, Correa L, Marra AR, Camargo LF, Pereira CA. Analysis of Vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study. BMC Infect Dis. 2007;7:88.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12685_CR8","doi-asserted-by":"publisher","first-page":"ofu006","DOI":"10.1093\/ofid\/ofu006","volume":"1","author":"J Libuit","year":"2014","unstructured":"Libuit J, Whitman A, Wolfe R, Washington CS. Empiric Vancomycin use in febrile neutropenic oncology patients. Open Forum Infect Dis. 2014;1(1):ofu006.","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 5","key":"12685_CR9","first-page":"S125","volume":"89","author":"P Rattanaumpawan","year":"2006","unstructured":"Rattanaumpawan P, Thamlikitkul V, Chokepaibulkit K, Lohsiriwat D, Aswapokee N. Vancomycin overuse in Siriraj hospital. J Med Assoc Thai. 2006;89(Suppl 5):S125\u201332.","journal-title":"J Med Assoc Thai"},{"key":"12685_CR10","doi-asserted-by":"crossref","unstructured":"Locke TE, Keeley AJ, Laundy N, Keil C, Hamilton J, Pandor A et al. Prevalence and risk factors for Staphylococcus aureus colonisation among healthy individuals in low- and middle-income countries: a systematic review and meta-analysis. J Infect. 2025;90(4).","DOI":"10.1016\/j.jinf.2025.106462"},{"issue":"Suppl 1","key":"12685_CR11","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","volume":"6","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Pfaller MA, Shortridge D, Zervos M, Jones RN. Twenty-Year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY antimicrobial surveillance program. Open Forum Infect Dis. 2019;6(Suppl 1):S47\u201353.","journal-title":"Open Forum Infect Dis"},{"key":"12685_CR12","unstructured":"National Antimicrobial Resistant Surveillance Center of Thailand. Antimicrobial resistance 2000\u20132022 [Internet]. 2022. Available at: http:\/\/narst.dmsc.moph.go.th\/data\/AMR%202000-2022-12M.pdf. Accessed October 10, 2023."},{"key":"12685_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1017\/ice.2018.123","volume":"39","author":"CD Waters","year":"2018","unstructured":"Waters CD, Caraccio J. Rate of positive cultures necessitating definitive treatment in patients receiving empiric Vancomycin therapy. Infect Control Hosp Epidemiol. 2018;39:989\u201390.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"12685_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/AAC.04523-14","volume":"59","author":"NH Kim","year":"2015","unstructured":"Kim NH, Koo HL, Choe PG, Cheon S, Kim M, Lee MJ, et al. Inappropriate continued empirical Vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59:811\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"12685_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/bcpt.13849","volume":"132","author":"M Abdel Jalil","year":"2023","unstructured":"Abdel Jalil M, Khaled F, Qaryouti F, Abu Hammour K, Alsous M, Al-Iede M. Vancomycin audit in the paediatric population: patterns of use and appropriateness of therapeutic drug monitoring. Basic Clin Pharmacol Toxicol. 2023;132:425\u201333.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"12685_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, Group KAGW. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.","journal-title":"Crit Care"},{"key":"12685_CR17","first-page":"375","volume-title":"Mandell, Douglas, and benett\u2019s principles and practice of infectious diseases","author":"BEAC Murray","year":"2020","unstructured":"Murray BEAC, Nannini EC. Glycopeptides and lipoglycopeptides. In: Bennett JEDR, Blaser MJ, editors. Mandell, Douglas, and benett\u2019s principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier Saunders; 2020. pp. 375\u201395.","edition":"9"},{"key":"12685_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12223-011-0017-1","volume":"56","author":"O Bouchami","year":"2011","unstructured":"Bouchami O, Achour W, Mekni MA, Rolo J, Ben Hassen A. Antibiotic resistance and molecular characterization of clinical isolates of methicillin-resistant coagulase-negative Staphylococci isolated from bacteremic patients in oncohematology. Folia Microbiol (Praha). 2011;56:122\u201330.","journal-title":"Folia Microbiol (Praha)"},{"key":"12685_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0924-8579(96)00363-9","volume":"8","author":"N Cimolai","year":"1997","unstructured":"Cimolai N, Trombley C, Zaher A. Oxacillin susceptibility of coagulase-negative staphylococci: role for MecA genotyping and E-test susceptibility testing. Int J Antimicrob Agents. 1997;8:121\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"12685_CR20","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, et al. 2017 infectious diseases society of america\u2019s clinical practice guidelines for Healthcare-Associated ventriculitis and meningitis. Clin Infect Dis. 2017;64:e34\u201365.","journal-title":"Clin Infect Dis"},{"key":"12685_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Clin Infect Dis. 2010;50:133\u201364.","journal-title":"Clin Infect Dis"},{"key":"12685_CR22","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56\u201393.","journal-title":"Clin Infect Dis"},{"key":"12685_CR23","first-page":"212","volume":"86","author":"M Chayakulkeeree","year":"2003","unstructured":"Chayakulkeeree M, Thamlikitkul V. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever. J Med Assoc Thai. 2003;86:212\u201323.","journal-title":"J Med Assoc Thai"},{"key":"12685_CR24","first-page":"173","volume":"101","author":"CSB Auesomwang","year":"2018","unstructured":"Auesomwang CSB, Chayakulkeeree M. Changes in etiologic microorganisms in Thai patients with chemotherapy-induced neutropenia and fever. J Med Assoc Thai. 2018;101:173\u201380.","journal-title":"J Med Assoc Thai"},{"key":"12685_CR25","first-page":"2432","volume-title":"Mandell, Douglas, and benett\u2019s principles and practice of infectious diseases","author":"MEFP Rupp","year":"2020","unstructured":"Rupp MEFP. Staphylococcus epidemidis and other Coagulase-Negative Staphylococci. In: Bennett JEDR, Blaser MJ, editors. Mandell, Douglas, and benett\u2019s principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier Saunders; 2020. pp. 2432\u201343.","edition":"9"},{"key":"12685_CR26","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1128\/CMR.00109-13","volume":"27","author":"K Becker","year":"2014","unstructured":"Becker K, Heilmann C, Peters G. Coagulase-negative Staphylococci. Clin Microbiol Rev. 2014;27:870\u2013926.","journal-title":"Clin Microbiol Rev"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12685-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:58:51Z","timestamp":1771595931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12685-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12685"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12685-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee, Faculty of Medicine Ramathibodi Hospital, Mahidol University (MURA2023\/843). As this was a retrospective study using anonymized patient data, the ethics committee waived the requirement for informed consent and assent in accordance with the institutional guidelines. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}